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We extended the kinetic method to determine the intrinsic affinities of nonvolatile organic
molecules with divalent metal ions and then applied the amended method to determine the
calcium affinities of peptide analogs of the calcium-binding site III of rabbit skeletal troponin
C. Metal–bis(peptide) complexes of the composition ([H2Pi 1 H2Pii] 2 H 1 Ca)
1, where H2P
is a neutral peptide, were introduced into the gas phase by fast atom bombardment. The
extended kinetic method recognizes that the dissociation characteristics of a singly charged,
bis(peptide) complexes of divalent metal ions are determined by not only the metal–ion affinity
but also the proton affinities of the neutral and deprotonated peptides. The modified method
requires one to measure the relative abundances of [H2P 2 H 1 Ca]
1, [H2P 1 H]
1, and
[H2P 2 H]
2 ions that form upon collisional activation of mixed peptide/metal complexes,
proton-bound peptide dimers, and deprotonated peptide dimers, respectively. We found, by
using the modified method, that the set of peptides has a different affinity order than that in
solution. Peptides with one aspartic acid have a higher intrinsic Ca21 affinity than those with
two aspartates. The location of the aspartic acid (Asp) residues at various positions also affects
the Ca21 affinity. Those peptides with one Asp in the middle of the chain have higher Ca21
affinities than those with Asp on the end because the former peptides offer greater
polarizability to stabilize the charge. Peptides with two Asp’s located in close proximity have
higher intrinsic calcium affinities than those with aspartates positioned further apart. (J Am
Soc Mass Spectrom 2000, 11, 770–779) © 2000 American Society for Mass Spectrometry
Intrinsic properties of molecules (i.e., those that de-pend on the molecule itself and not on solvent)provide an important benchmark for understanding
properties in solution and are usually investigated by
theoretical calculations and gas-phase experiments.
Proton and metal–ion affinities are examples of intrinsic
properties and have been measured successfully for
small, volatile ligands by measuring equilibrium con-
stants or dissociation thresholds in the gas phase.
Application of the methods has produced extensive
data bases of, for example, proton and singly charged
metal–ion affinities of both small ligands and larger,
more complex ones such as cyclic and acyclic poly-
ethers, amines, alcohols, and carboxylic acids [1–5].
Intrinsic properties of involatile biological molecules
are not amenable to equilibrium studies but can be
determined by the kinetic method of Cooks [6, 7]. The
method takes as its subject system a loosely bound
complex of two molecules that are bound to the cation
of interest. When the complex undergoes competitive
dissociation to release either molecule bound to the
cation, the molecule with the lower cation affinity is
released preferentially. If secondary fragmentations do
not occur, than the dissociation rate constants of the two
reactions are proportional to the abundances of proton-
ated (or cationized) monomers. The operative assump-
tions are that dissociation rates of two unimolecular
reactions can be related to proton or cation affinities if
(a) the reverse activation-energy barrier is zero or
minimal, and (b) the competitive fragmentations of a
proton-bound dimer into two protonated monomers
have similar frequency factors.
The first applications of the kinetic method [8] in-
volved measurements of proton affinities of volatile
ligands. These served as important tests of theory and
as a validation of the method, justifying its later exten-
sion to nonvolatile biological ligands. Loosely bound
complexes of nonvolatile ligands can be introduced into
the gas phase by fast atom bombardment (FAB) or
electrospray ionization (ESI). The kinetic method has
been coupled with these ionization methods to measure
successfully the proton and metal–ion affinities of pep-
tides [9–17] and nucleotides [18–20].
Turning to interactions of metal ions, particularly
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Ca21 and Mg21, with peptides and proteins in solution
or the solid state [21–24], we find a subject that has been
extensively investigated. Calcium is particularly impor-
tant because it is central to complex intracellular mes-
senger systems that mediate many biological processes,
such as muscle contraction, secretion, glycolysis and
gluconeogenesis, ion transport, cell division, and
growth. One of the links in the messenger system is a
class of highly homologous Ca21-binding proteins [25–
28] that undergo Ca21-dependent conformational
changes. A family of these calcium-binding proteins has
from one to four calcium-binding sites; each site exists
as helix–loop–helix arrangement that is 31 residues in
length.
The portion of the protein that interacts with Ca21 is
part of a segment of 12 amino-acid residues that com-
prise the polypeptide loop between the helices [29–31].
The interacting residues are at positions 1, 3, 5, 7, 9, and
12 of the loop and generally have side chains that
contain carbonyl, carboxyl, and alcohol functional
groups (e.g., Asp, Asn, Glu, Ser, and Thr). One ap-
proach to study the Ca21 affinity of the site is to use
model peptides of appropriate sequence motifs and
determine their affinities in solution. 1H NMR spectros-
copy, for example, has been used for that purpose
[32–35]. The advantage of NMR is the capability for
direct measurement of the metal-binding constants in
aqueous solution, whereas one limitation for Ca21 bind-
ing studies is the requirement to use Ca21 surrogates
such as La31 and Tb31 to enhance the binding to
detectable levels and to minimize the complexity of the
spectral responses due to signal superpositions.
An understanding of intrinsic interactions of Ca21 or
Mg21 ions with peptides and proteins, however, is only
beginning to emerge [36–40]. The main goals of studies
published thus far have been the determination of
metal-binding sites [36, 37, 39, 40] and stoichiometry
[38] and the use of collisional activation of metal–ion
complexes as an alternative to activating [M 1 H]1 ions
for peptide sequencing [39]. Both cationic [39] and
anionic [36, 37, 40] metal/peptide complexes were
investigated, and the existence of gas-phase metal–
bis(peptide) complexes [36] in forms of [2pept 2 H 1
Met]1 and [2pept 2 3H 1 Met]2 was established. The
affinities of peptides for alkaline-earth or transition-
metal (II) ions, however, have not been measured in the
gas phase.
To determine the Ca21 affinities of small peptides
that are analogs of the calcium-binding site III of rabbit
skeletal troponin C, we modified and extended the
kinetic method to include interactions with divalent
metal ions. Specifically, we determined the Ca21 affin-
ity of peptides containing variable numbers of Asp and
Asn ligating residues in various positions of a set of
hexapeptides. We chose the peptides to model the site
III of rabbit skeletal troponin C because data on affinity
of La31 to these peptides in solution are available
[33–35]. The modeling is not complete because we
started with peptides that contained only six amino
acids, allowing us to investigate the influence of chang-
ing the ligating amino acids at positions 1, 3, and 5, but
not at 7, 9, and 12.
Experimental
Reagents
The peptides used in this work were prepared by
stepwise solid-phase peptide synthesis in the Depart-
ment of Pathology at the Washington University School
of Medicine. The crude peptides were purified by
reverse phase high performance liquid chromatography
(HPLC) by using a C-18 column, and fractions were
collected and lyophilized. The identity of the peptides
was confirmed by FAB and tandem mass spectrometry
of the [M 1 H]1 ions. They were at least 85% pure on
the basis of mass spectrometric peak intensities.
The cation-exchange resins (AG 50W-X8, mesh size:
200–400 mm) were purchased from the Bio-Rad Labo-
ratories (Hercules, CA) in the H form. Conversion to the
Ca21-saturated resins was achieved by washing the H
form of the resin with five-bed volumes of ;8 M
calcium acetate. Any residual Ca(OAc)2 solution was
washed out by flushing the resin with three-bed vol-
umes of deionized water (1018 V 1 cm) [41].
Instrumentation
Mass spectrometric experiments were carried on a VG
ZAB-T (Manchester, UK), four-sector tandem instru-
ment [42], consisting of two high-mass, double-focusing
mass spectrometers of BEBE design. The instrument
was equipped with a Cs1 gun operated at 25 kV that
provided a 17-keV Cs1 ion beam at the sample. The
accelerating voltage for all experiments was 8 kV. Mass
spectra of FAB-produced ions were acquired by using
the first stage mass spectrometer (MS1) at a mass
resolving power of approximately 1500 (10% valley
depth). The second stage (MS2) was used to obtain
product-ion spectra after selecting the FAB-produced
precursor ions with MS1 and collisionally activating
them with sufficient helium gas to give 50% main-beam
suppression. The product ions, formed in a 4-kV floated
collision cell in the third-field-free region, were regis-
tered with the single-point detector. To obtain metasta-
ble-ion spectra, the conditions were the same except no
collision gas was introduced into the collision cell,
which was now at ground potential. Data acquisition
was carried out with OPUS V 3.1X data system, which
was interfaced to the mass spectrometer by a VG SIOS
I unit.
Procedures
For acquiring both mass spectra and product-ion CAD
spectra, 1 mL of a 3-NBA matrix containing 20–50 beads
of calcium-saturated cation-exchange resin was mixed
with 1 mL of 1 mg/mL peptide solution. The sample
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probe was then introduced into the mass spectrometer,
and the sample was bombarded with the Cs1 beam to
cause desorption. Ten to twenty 1- or 2-s scans were signal
averaged to obtain the spectrum of desorbed ions.
Two calcium–bis(peptide) complexes comprised of
NRDANG and NRNGDG and of DRNADG and
NRDADA were also formed by electrospray ionization
and submitted to low-energy collisional activation on
an ion-trap instrument (Finnigan LCQ, San Jose, CA).
The spectra were more complicated than those obtained
with the magnetic sector instrument; the precursor ions
underwent predominant H2O and/or NH3 losses. For
the second case, the water loss was so dominate that the
losses of either peptide were barely competitive. As a
result, we used FAB and tandem four-sector mass
spectrometry (high-energy collisional activation) to
carry out the affinity measurements.
Results and Discussion
Formation of ([H2Pi 1 H2Pii] 2 H 1 Ca)
1 Ions
We formed gas-phase Ca–bis(peptide) complexes by
FAB. To generate a singly charged complex ([H2Pi 1
H2Pii] 2 H 1 Ca)
1, one proton must be removed from
one peptide or the other and be replaced by a doubly
charged Ca21 ion. We were able to form readily the
calcium-bound–bis(peptide) complexes by bombarding
a solution of the peptides in a 3-NBA matrix, to which
we added several beads of calcium-saturated, cation-
exchange resin, on a FAB sample probe [43]. Using a
metal-exchange resin for incorporation of the metal into
bis(peptide) complexes improves the signal-to-noise ra-
tio for both the precursor-ion and the product-ion
spectrum. For best result, 20–50 resin beads (mesh size
of 200–400 mm) were used because they probably
provide the optimum number of Ca21 ions and a good
surface area-to-volume ratio. If we used more than 100
beads, the absolute abundance of Ca21–bis(peptide)
complexes decreased. The advantage of introducing
Ca21 by a metal-exchange resins rather than by using a
Ca(OH)2-saturated matrix is that the formation of the
Ca21–bis(peptide) complex can be readily adjusted by
varying the number of beads [43].
We propose that the Ca-bound-bis(peptide) complexes
have a structure in which the metal ion simultaneously
interacts with the two peptides via formation of octahe-
dral complexes with at least six-coordinate bonding [22].
One of these bonds must be largely ionic, involving the
positively charged Ca21 and the peptide, which has be-
come negatively charged by removal of one proton. The
source of the proton that is lost from the peptide is more
likely to be the side-chain carboxyl group of an Asp or Glu
rather than an amide function. The intrinsic acidities of
NH donors fall in the range of 352–355 kcal/mol, whereas
those of carboxylic groups are slightly higher at 345–350
kcal/mol [44–46]. Remarkably, the difference between
the pKas of these groups in solution is approximately 13
units in favor of the carboxylic group. We designed the
ligand peptides to have different sequences (see Table 1):
one of which contains the native binding motif and the
others which contain small perturbations of that native
motif. This satisfies one requirement of the kinetic meth-
od; namely, that the binding ligands be similar in structure
and affinity [6]. Furthermore, the peptides contained
amide rather than carboxylic-acid C termini, giving them
some resemblance to a protein, and lacked a free C-
terminal carboxyl group to promote bonding with the Asp
or Glu side chains.
As was shown earlier by Hu and Gross [36], FAB can
produce negatively charged, mixed peptide/metal
complexes from two different peptides. We were able to
form similar 11 complexes by using positive-ion FAB.
For the peptides AsnArgAspAlaAsnGly (NRDANG)
and AsnArgGluAlaAsnGly (NREANG), for example,
three Ca-bound, bis(peptide) complexes are possible,
and each forms (Figure 1). Two are homopeptide/metal
complexes of m/z 1327 and 1355, and the third is a
heteropeptide/metal complex of intermediate m/z 1341.
CAD of Ca21–Bis(peptide)/Metal Complexes
Competition between two peptides can be measured from
metastable-ion or CAD spectra. The abundances of prod-
uct ions that are seen in these two spectra are identical
within experimental error for two sets of peptides: Asn-
Table 1. Sequence of peptides for Ca21-affinity studies
[M 1 H]1 [M 2 H 1 Ca]1
AspArgAsnAlaAsnGly (DRNANG) 645 683
AsnArgAspAlaAsnGly (NRDANG) 645 683
AsnArgAsnAlaAspGly (NRNADG) 645 683
AsnArgAspAlaAsnAla (NRDANA) 659 697
AsnArgAsnGlyAspGly (NRNGDG) 631 669
AsnArgGluAlaAsnGly (NREANG) 659 697
AspArgAsnAlaAspGly (DRNADG) 646 684
AsnArgAspAlaAspAla (NRDADA) 660 698
AspArgAspGlyAsnGly (DRDGNG) 632 670
ArgAspAspAlaAsnGly (RDDANG) 646 684
ArgAspAlaGlyAspAsn (RDAGDN) 646 684
Figure 1. Full scan FAB mass spectrum of peptides NRDANG
and NREANG loaded with Ca21.
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ArgAspAlaAsnAla (NRDANA) and AsnArgAspAlaAsn-
Gly (NRDANG) as well as AsnArgAspAlaAsnAla and
AspArgAsnAlaAsnGly (DRNANG). Although both spec-
tra are equally simple, the intensities of product-ion sig-
nals are a factor of approximately 100 times lower in the
metastable-ion spectra than those in the CAD spectra.
Therefore, we chose CAD to measure the competition
because it not only provides a better signal-to-noise
ratio (S/N) than does the metastable-ion method but
also insures that the decomposition takes place from
sufficiently high energy states that both products can be
produced. The inability to use metastable-ion decom-
positions in a meaningful way precludes making esti-
mates of the entropy of complexation. The similarity
between metastable-ion and CAD spectra, however,
suggests that the dDS for the interactions of the two
peptides is small, which is another requirement for
success of the kinetic method [6]. There are other
fragment ions, formed by the loss of ammonia from
[H2Pi 2 H 1 Ca]
1 ion, and their abundances were
taken into account in the calculation of the total ion
intensity of the corresponding [HPi 1 Ca]
1 ion.
The patterns of product ions that form upon CA of
Ca21–bis(peptide) complexes depend on the number of
acidic side-chain groups in the peptide. Those homo
complexes of DRNANG, NRDANG, NRNADG, and
NREANG, which contain only one Asp or Glu, disso-
ciate upon CAD to give abundant [H2P 2 H 1 Ca]
1
ions accompanied by low abundance [H2P 2 H 1
Ca 2 NH3]
1 ions. On the other hand, homocomplexes
of peptides that contain two acidic side chains (two Asp
residues or an Asp and Glu) dissociate to give [H2P 2
H 1 Ca]1 and [H2P 1 H]
1. The neutral accompanying
formation of the latter product ion is a calcium salt of
the peptide. These trends are illustrated for homocom-
plexes of NRDANG (Figure 2), which gives [H2P 2
H 1 Ca]1 ions of m/z 683, whereas the bis(complex) of
DRNADG dissociates to yield both [H2P 2 H 1 Ca]
1
ions of m/z 684 and [H2P 1 H]
1 ions of m/z 646.
Formation of [H2P 2 H 1 Ca]
1 ions from the homopep-
tide/metal complexes (Scheme 1) is analogous to the
behavior of negative metal–bis(peptide) complexes that
produce [H2P 2 3H 1 Ca]
2 ions upon CA [36]. The frag-
mentation to give the [H2P 1 H]
1 ion involves displace-
ment by a Ca21 ion of two acidic protons from the peptide
molecule (Scheme 2), rationalizing why this process re-
quires at least two acidic side chains in one of the peptides
of the bis(peptide) complex. These results are best ex-
plained by postulating that an acid side chain of Asp or
Glu is deprotonated and serves as the principal binding
site (anchor) for Ca21. Moreover, the ability of the com-
plex to decompose to give both Ca21 and non-Ca21-
containing peptides is evidence that the metal ion and the
protons are mobile in the complex, which is another
requirement for success of the kinetic method [6].
Relation of Product-Ion Abundances and Ca21
Affinity
On the basis of the results with bis(homopeptide) com-
plexes, we expect that bis(peptide) complexes contain-
ing two different peptides fragment by four reactions
(eqs 1–4). This is understood by viewing the bis(pep-
tide) complex to be composed of two peptides, each
deprotonated on a side chain, sharing an H1 and Ca21.
The enthalpy changes for these reactions are given by
eqs 5–8:
DHrxn(1) 5 Df H(H2Pii) 1 Df H(HPiCa
1)
2 Df H(complex) (5)
Figure 2. CAD mass spectra of Ca21-bound homobis(peptide)
complexes: (A) NRDANG and (B) DRNADG.
Scheme 1
Scheme 2
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DHrxn(2) 5 Df H(H3Pii
1) 1 Df H(PiCa)
2 Df H(complex) (6)
DHrxn(3) 5 Df H(H2Pi) 1 Df H(HPiiCa
1)
2 Df H(complex) (7)
DHrxn(4) 5 Df H(H3Pi
1) 1 Df H(PiiCa)
2 Df H(complex) (8)
It is now convenient to combine eqs 5–8 to give eq 9:
dDHrxn 5 DHrxn(314) 2 DHrxn(112)
5 @Df H(H3Pi
1) 2 Df H(H3Pii
1)#
1 @Df H(PiiCa) 2 Df H(PiCa)#
1 @Df H(H2Pi) 2 Df H(H2Pii)#
1 @Df H(HPiiCa
1) 2 Df H(HPiCa
1)# (9)
We now seek to write the four expressions in brackets
(eq 9) in terms of proton and calcium-ion affinities. The
proton affinities of the neutral peptides are given by eqs
10 and 11:
H2Pi 1 H
1 5 H3Pi
1 PA*(H2Pi) 5 2DHrxn(10)
(10)
H2Pii 1 H
1 5 H3Pii
1 PA*(H2Pii) 5 2DHrxn(11)
(11)
DPA* 5 PA*(H2Pii) 2 PA*(H2Pi) (12)
Substituting and rearranging, we obtain eq 13:
Df H(H3Pi
1) 2 Df H(H3Pii
1) 5 DPA* 1 Df H(H2Pi)
2 Df H(H2Pii) (13)
We now express the proton affinities of the negatively
charged peptides by eqs 14 and 15:
HPi
2 1 H1 5 H2Pi PA(HPi
2) 5 2DHrxn(14)
(14)
HPii
2 1 H1 5 H2Pii PA(HPii
2) 5 2DHrxn(15)
(15)
DPA 5 PA(HPii
2) 2 PA(HPi
2) (16)
Substituting for the proton affinities of the negative
peptide ions and rearranging, we obtain eq 17:
Df H(H2Pi) 2 Df H(H2Pii) 5 DPA 1 Df H(HPi
2)
2 Df H(HPii
2) (17)
We now consider calcium affinities of the singly nega-
tively charged peptides, which can be expressed by eqs
18 and 19:
HPi
2 1 Ca21 5 HPiCa
1
CA(HPi
2) 5 2DHrxn(18) (18)
HPii
2 1 Ca21 5 HPiiCa
1
CA(HPii
2) 5 2DHrxn(19) (19)
DCA 5 CA(HPii
2) 2 CA(HPi
2) (20)
Substituting for the calcium ion affinities and rearrang-
ing, we obtain eq (21):
Df H(HPiiCa
1) 2 Df H(HPiCa
1) 5 2DCA
1 Df H(HPii
2) 2 Df H(HPi
2) (21)
We also must consider the calcium ion affinities (CA*)
of the peptide anions in a different reaction in which a
proton is displaced (eqs 22–24):
HPi
2 1 Ca21 5 PiCa 1 H
1
CA(HPi
2)* 5 2DHrxn(22) (22)
HPii
2 1 Ca21 5 PiiCa 1 H
1
CA(HPii
2)* 5 2DHrxn(23) (23)
DCA* 5 CA(HPii
2)* 2 CA(HPi
2)* (24)
Substituting for the calcium ion affinities and rearrang-
ing, we obtain eq 25:
Df H(PiiCa) 2 Df H(PiCa) 5 2DCA* 1 Df H(HPii
2)
2 Df H(HPi
2) (25)
We are now in position to reformulate eq (9) by
substituting with eqs 13, 17, 21, and 25 to obtain eq 26:
dDHrxn 5 [DPA* 1 Df H(H2Pi)
2 Df H(H2Pii)] 1 [DPA 1 Df H(HPi
2)
2 Df H(HPii
2)] 1 [2DCA 1 Df H(HPii
2)
2 Df H(HPi
2)] 1 [2DCA* 1 Df H(HPii
2) 2 Df H(HPi
2)]
(26)
Combining terms and substituting, we obtain the useful
and simple result given in eq 27, where we see that the
difference in enthalpies of reaction are proportional to
both the differences in proton and calcium-ion affinities:
dDHrxn 5 DPA* 1 DPA 1 DPA 2 DCA 2 DCA*
(27)
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We now define a new term, DCAtotal, which is the sum
of the two calcium affinities and can be viewed as an
overall or total calcium ion affinity:
DCA 1 DCA* 5 DCAtotal (28)
We now substitute eq 28 into eq 27 to give eqs 29 and
30:
dDHrxn 5 DPA* 1 2DPA 2 DCAtotal (29)
or
DCAtotal 5 DPA* 1 2DPA 2 dDHrxn (30)
For the peptides with one aspartic acid, eq 30 be-
comes eq 31 because only two reaction channels are
possible:
DCAtotal 5 DPA 2 dDHrxn (31)
We now assume, as is usual for the kinetic method, that
differences in proton affinities and enthalpies of reac-
tions can be related to ion abundances:
DPA* ; lnS I*(H3Pii)1I*(H3Pi)1D ; DPA ; lnS
I(HPi)2
I(HPii)2
D (32)
The differences in proton affinities of the neutral and
deprotonated peptides are given by eq 32, and the
differences in reaction enthalpies for complexes of pep-
tides, each containing two Asp residues, or each con-
taining one Asp, are given by eqs 33 and 34, respec-
tively:
dDHrxn ; lnS I(HPiiCa)1 1 I(H3Pi)1I(HPiCa)1 1 I(H3Pii)1D (33)
dDHrxn ; lnS I(HPiiCa)1I(HPiCa)1D (34)
In the equations, I*(H3Pii
1) and I*(H3Pi
1) are the signal
intensities corresponding to the product ions that are
formed in the dissociation of the [H2Pi . . . H
1 . . . H2Pii]
1
complexes, I(HPi
2) and I(HPii
2) are the signal inten-
sities corresponding to the product ions that are formed
in the dissociation of the [HPi
2 . . . H1 . . . HPii
2]2
complexes, and I(HPiiCa
1), I(HPiCa
1), I(H3Pi
1),
and I(H3Pii
1) are the signal intensities corresponding
to ions that are formed in the dissociation of cal-
cium–bis(peptide) complexes. We now substitute
the signal-intensity eqs 32 and 33 into eq 30 to ob-
tain eq 35, which gives the difference in calcium affin-
ities for two peptides, each containing two Asp
residues:
DCAtotal 5 lnSF I*(H3Pii)1I*(H3Pi)1GF
~I(HPi)2)
2
~I(HPii)2)
2G
3 F I(HPiCa)1 1 I(H3Pii)1I(HPiiCa)1 1 I(H3Pi)1GD (35)
Similarly, for peptides each containing one Asp, we
substitute signal-intensity eqs 32 and 34 into eq 31 to
obtain eq 36:
DCAtotal 5 lnSF I(HPi)2I(HPii)2GF
I(HPiCa)1
I(HPiiCa)1
GD (36)
The difference in calcium ion affinity is related not only
to intensities of signals for the calcium-bound mono-
meric peptides but also to those for their protonated
and deprotonated forms. (In the limit when differences
in proton affinities of the deprotonated peptides are
large, the applicability of eq 36 may become question-
able. That is not the case here.)
To extract the Ca21 affinities from the intensities of prod-
uct ions formed from the calcium–bis(peptide) complexes,
we had to account for the proton affinities of the neutral
and anionic peptides. Therefore, we collisionally activated
three complex ions: [(H2Pi 1 H2Pii) 2 H 1 Ca]
1,
[H2Pi . . . H
1 . . . H2Pii]
1, and [HPi
2 . . . H1 . . . HPii
2]2. Typ-
ical data for the three experiments are shown in Figure 3
(for peptides with one Asp each), Figure 4 (for peptides
with two Asp residues each), and Figure 5 (for a peptide
with one and the other with two Asp residues).
Comparison of the Gas-Phase Ca21 Affinity of
Peptides with One Asp Residue
We studied the influence of the position of an Asp
residue on the gas-phase Ca21 affinity of peptides that
Figure 3. CAD mass spectra of Ca21- and H1-bound dimers of
peptides with one Asp (NRNADG and NRDANA).
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are related to the binding motif for Ca21 in site III of
rabbit skeletal troponin C. To do this, we synthesized
DRNANG, NRDANG, NRNADG, NRDANA, and
NRNGDG. Because the first three peptides of the series
are isomers, the synthesis of the other two peptides
differing by replacing Gly with Ala was required so that
we could distinguish complexes of these peptides by
using mass spectrometry.
The CAD spectra show that mixed peptide/metal
complexes dissociate to two fragments ions: [H2Pi 2
H 1 Ca]1 and [H2Pii 2 H 1 Ca]
1 ions. An assumption
in applying the kinetic method is that no reverse
activation energy barriers exist. Although this assump-
tion is questionable, nevertheless, the usual procedure
is to replace the difference in activation energies for the
formation of [H2Pi 2 H 1 Ca]
1 and [H2Pii 2 H 1
Ca]1 with thermodynamic parameters (eq 9). Therefore,
applying the kinetic method and comparing relative
intensities of ion signals, we can estimate differences in
the enthalpies for dissociation of the Ca21-bound-pep-
tide complexes. The peptides that we chose to compare,
however, are different not only in the position of Asp
but also in the numbers of Gly or Ala residues. For that
reason, we carried out control experiments to evaluate
the effect of changing Ala for Gly on the Ca21 affinities
of the peptides. This exchange leads to no detectable
difference in the Ca21 affinities of the peptides (Table 2).
The results show that the peptide with Asp in the
middle of the peptide chain (NRDANA) has the highest
affinity for calcium among the peptides with one Asp
residue (Table 3). Its Ca21 affinity is greater than those
of NRNADG and DRNANG by 0.2 and 0.1, respec-
tively. The numbers in the table are proportional to the
differences in calcium affinities by an RT factor, but
because we do not know T, or even an effective T, we
cannot express the values in standard energy units [6].
Nevertheless, we can order the peptides in terms of
relative affinities.
The calcium affinities of peptides parallel their pro-
ton affinities, which are also highest for the peptide
with Asp in the middle of the chain. Similar trends exist
for proton affinities of aliphatic amines, alcohols, and
carboxylic acids [47]. We may understand the trend by
considering a peptide with an Asp in the center to be
analogous to an aliphatic acid that contains a branched
alkyl group. Branched alkyl groups cause compounds
to have a higher acidity than those with straight chain
substituents [48], which was attributed to the stabilizing
effect of the greater polarizability of two alkyl groups
on the negative ion. For example, the acidity of n-
pentanoic acid (21449 kJ/mol) is the lowest among its
other isomers that have branched side chains (7 kJ/mol
lower than that of tert-pentanoic acid and 4 kJ/mol
lower than that of isopentanoic acid) [48].
Comparison of the Gas-Phase Ca21 Affinities of
Peptides with Two Asp Residues
We also determined the relative calcium affinities of
peptides that contain two Asp residues but differ in the
location of the Asp (e.g., DRNADG, RDAGDN,
NRDADA, DRDGNG, and RDDANG). The motivation
for looking at the difference in relative calcium affinity
of isomeric peptides with Asp residues in different
locations is from solution chemistry where peptides
with remote locations of Asp have higher Ca21 affinities
than do peptides with Asp in nearby positions [33–35].
The trends for gas-phase species are different than
those for species in solution. Peptides that contain Asp
residues next to each other have higher Ca21 affinities
than do peptides that contain Asp residues that are
more separated (Table 2). For example, the peptide
RDDANG binds calcium with a significantly greater
affinity than does peptide DRNADG (Table 3). The
stronger bonding of calcium to a peptide with Asp
residues next to each other has analogy with organic
Figure 4. CAD mass spectra of Ca21- and H1-bound dimers of
peptides with two Asp’s (DRDGNG and NRDADA).
Figure 5. CAD mass spectra of Ca21- and H1-bound dimers of
peptides with one and two Asp’s (NRDANG and NRDADA).
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diacids that have nearby carboxylic groups and have
lower pKa1’s than those with remote functional groups
[49]. The close proximity of one carboxyl group to
another enhances the acidity of the latter.
Comparison of the Gas-Phase Ca21 Affinity of
Peptides with Different Numbers of Asp Residues
We chose pairs of peptides, one of which contains one
and the other of which contains two Asp residues, to
complete the comparisons. Peptides with one Asp have
higher Ca21 affinities than do peptides with two. For
example, the peptide NRDANG has a greater calcium
affinity than peptide NRDADA by 2.2 units (Table 3).
Replacement of Asn for Asp in the peptide chain affects
more strongly the Ca21 affinity than repositioning the
Asp residue along the peptide chain. These findings
suggest that asparagine is a better ligand than neutral
aspartic acid [50]. One explanation is that the amide
carbonyl oxygen of asparagine is more basic than that of
a carboxylic group because –C(O2)¢NH2
1 of Asp con-
tributes more strongly to the overall structure than does
–C(O2)¢OH1 of Asp. (The gas-phase basicity of aspartic
acid is 875 kJ/mol, whereas that of asparagine is 891.5
kJ/mol [50].) This effect does not pertain in solution
where, at physiological pH, the side-chain carboxylic
acids of Asp and Glu are ionized to give better ligands
than neutral –CONH2 and –COOH. In these gas-phase
experiments, the extent of ionization is limited to one
side chain, not two, of Asp or Glu residues. Thus, the
lack of consistency between the intrinsic Ca21 affinities
and those in solution can be understood (Table 4).
Consistency Check
The intrinsic Ca21 affinities can be tested for internal
consistency by using overlapping calcium affinity mea-
surements (Table 3). The differences in the Ca21 affini-
ties of peptides are related to the differences in their
thermodynamic properties, which are additive. We may
check the self-consistency of our results by manipulat-
ing Ca21 affinities for two peptides to obtain the value
for third one. For example, knowing the difference
between Ca21 affinities of peptides NRDANA and
NRDADA (2.2) and the difference between Ca21 affin-
ities of peptides NRDAND and DRDGNG (2.0), we can
compute the difference between peptides DRDGNG
and NRDADA to be 0.2; the measured result is 0.3.
There is also consistency between the computed and
measured Ca21 affinities for other peptide pairs as can
be ascertained by other similar comparisons of the data
in Table 3. The consistency of the data is strong evi-
dence that affinities are indeed being measured rather
Table 2. Results of proton affinities, enthalpies of reactions, and calcium affinities of peptides
Peptide 1 Peptide 2
Experiment 1 Experiment 2 Experiment 3
dDHrxn DCAtot
aI(HPi)2 I(HPii)2 DPA I*(H3Pi)1 I*(H3Pii) DPA* I(HPiCa)1 I(HPiiCa) I(H3Pi)1 I(H3Pii)1
DRNANG NRDANA 1 0.75 0.25 0.75 1 0.25 0.7 1 0.30 0.45
NRNADG NRDANA 1 0.80 0.20 0.70 1 0.30 0.68 1 0.32 0.42
NRDANG NRDANA 1 0.95 0.05 0.95 1 0.05 0.95 1 0.05 0.10
DRNADG NRDADA 1 0.72 0.28 0.72 1 0.28 0.93 1 0.95 1 0.02 0.82
DRNADG DRDGNG 1 0.58 0.42 0.80 1 0.20 0.82 1 0.71 1 20.11 1.15
NRDADA DRDGNG 1 0.92 0.08 0.98 1 0.02 0.85 1 0.71 1 20.14 0.32
NRDADA RDDANG 1 0.74 0.26 1 0.96 20.04 0.95 1 0.60 1 20.35 0.83
DRDGNG RDAGDN 0.7 1 20.30 0.94 1 0.06 1 0.53 0.61 1 20.08 20.46
NRDANG NRDADA 0.18 1 20.82 1 0.48 20.52 0.85 1 0.15 1 20.70 21.46
NRNADG NRDADA 0.38 1 20.62 1 0.63 20.37 0.75 1 0.20 1 20.55 21.06
NRDANG DRDGNG 0.44 1 20.56 1 0.37 20.63 0.75 1 0.13 1 20.62 21.13
NRNADG DRDGNG 0.46 1 20.54 1 0.46 20.54 0.9 1 0.16 1 20.74 20.88
aLong term STD is 0.08.
Table 3. Overlapping results for the relative Ca21 affinity
Table 4. Comparison of Ca21 gas phase and solution affinity
of peptides
Gas phase Solution
AsnArgAspAlaAsnGly (NRDANG) 1 4
AsnArgAsnAlaAspGly (NRNADG) 2 5
AspArgAsnAlaAsnGly (DRNANG) 3 6
AspArgAspGlyAsnGly (DRDGNG) 4 3
AsnArgAspAlaAspAla (NRDADA) 5 2
AspArgAsnAlaAspGly (DRNADG) 6 1
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than some weak, nonspecific interaction of one peptide
with another that is strongly bound to Ca21.
Conclusion
We extended the kinetic method for the determination
of relative Ca21 affinities of peptides, an extension that
should be applicable to other divalent metal ions.
Relative Ca21 affinities of peptide analogs of the calci-
um-binding site III of rabbit skeletal troponin C depend
on the positions and numbers of aspartic acid and
asparagine residues in the peptide, and they are differ-
ent in the gas phase than in solution. Peptides with one
aspartic acid and two asparagine residues have higher
intrinsic Ca21 affinity than those with two aspartates
and one asparagine presumably because the asparagine
side chain is a better ligand than is aspartic acid.
Peptides with two Asp residues located in close prox-
imity have higher intrinsic calcium affinities than those
with two Asp residues positioned further apart. Among
peptides with one Asp, those with Asp in the middle
display the highest Ca21 affinity presumably because
polarizability of two adjoining peptide chains stabilizes
the charge more than do peptides with Asp at the
periphery.
Although the kinetic method is based on a number of
assumptions [6], some of which are questionable, it has
stood the test of greater than 20 years of scrutiny and
evaluation. Its resilience is fortunate because it may be
the only method for determining intrinsic properties of
nonvolatile biomolecules. Most of the experimental
requirements of the kinetic method have been met in
the design of this study. The ligands, as hexapeptides,
differ in only minor ways from each other, guarantee-
ing that the frequency factors for the decomposition
reactions are similar. The requirement that the ligands
be weakly bound seems to be met as the only significant
decomposition of the bis(peptide) complexes is to dis-
sociate to single peptides. Another requirement is that
the cations should shuttle easily between the two li-
gands, which is not unreasonable when one considers
that the two peptides may be considered to be depro-
tonated and exist as anions in the complex. Finally, the
entropic changes, dDS, should be negligible, and the
near identity of metastable-ion and CAD spectra is
evidence that these changes are small.
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